Stada Moves Closer To Top-3 Target With Strong Showing In 2022

 
• By Tom Gallen

Stada's Consumer Healthcare business grew faster than the market in 2022, and outpaced many of its peers, taking the company closer to its goal of becoming a top-three European OTC player.

Steps
• Source: Shutterstock

Stada took a significant step towards becoming Europe’s third-largest OTC player in 2022 as its Consumer Healthcare business reported sales up by a quarter.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Europe

More from Geography